Lauren Charles, a chief data scientist at PNNL, showcased the vital research coming out of her program at The National Academies Forum workshop in Washington, D.C., January 15–16, 2025.

PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.

PNNL will engage with transmission planners and other regional partners through technical assistance and listening sessions with the goal of exploring opportunities to integrate equity into transmission planning.

Researchers will explore climate, pathogens and energy-efficient microelectronics using 3 million node hours on the nation’s supercomputers.

Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.

Beyond melting ice and higher temperatures: On Earth Day, scientists consider how climate change will affect national security.

PNNL electrical engineer Samrat Acharya led a team that earned the 2024 IEEE Innovative Smart Grid Technologies Conference Best Paper Award.

Glenn Fugate was selected to serve on the American Chemical Society's Science Committee.

ExaGO, a power grid simulation and optimization platform developed at PNNL is the first of its kind to run on Frontier.

Brian Milbrath, a physicist at Pacific Northwest National Laboratory (PNNL), was selected as a new Task Leader for the PrepCom’s Working Group B.

Microbes that were previously frozen in soils are becoming more active. This study demonstrates the diverse RNA viral communities found in thawed permafrost.

New PNNL research makes it easier to differentiate between chemical and nuclear explosions.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

PNNL researchers developed a new model to help power system operators and planners better evaluate how grid-forming, inverter-based resources could affect the system stability.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Mary Lancaster, epidemiologist and data scientist, co-authored a chapter on cyberbiosecurity for the NATO Science for Peace and Security book series.